Videos

Samin Sharma, MD, director of interventional cardiology and director of clinical cardiology, Mount Sinai Hospital, New York, discusses the first-in-human use of the Magenta Elevate percutaneous left ventricular assist device (pLVAD) with a small 10 French size and 5.5 liters per minute of hemodynamic support.

Initial results promising for world's smallest percutaneous heart pump

A new 10 French percutaneous heart pump could help greatly reduce vascular complications and improve cardiogenic shock outcomes.

Jamie Bourque, MD, medical director of the nuclear cardiology and stress laboratory, and medical director of the echocardiography lab, at the University of Virginia, discusses a new multimodality consensus statement for imaging cardiac amyloidosis. This area has rapidly expanded over the past couple years now that there are drugs to treat the condition.

New ASNC quality metrics will support standardization of imaging for cardiac amyloidosis

Interest in cardiac amyloidosis has been on the rise in recent years. Jamie Bourque, MD, talked to Cardiovascular Business about an upcoming consensus statement focused on using cardiac imaging to evaluate patients for signs of this serious condition. 

Rob deKemp, PhD, FASNC, University of Ottawa, Canada, explains new nuclear cardiac imaging dose lowering techniques for PET and SPECT.

How to achieve much lower radiation doses in cardiac nuclear imaging

The radiation doses associated with CT have decreased significantly, leaving nuclear cardiology as the modality with the highest doses in all of cardiac imaging. Rob deKemp, PhD, talked to us about some of the many ways imagers can work to address this issue.

Professor Keith Channon, MD, MB ChB, FRCP, interventional cardiologist and the British Heart Foundation Professor Cardiovascular Medicine at the University of Oxford, and a co-founder of Caristo, explained an AHA 2023 study where AI identified coronary inflammation as a major silent risk factor and a strong predictor of heart attack risk.

AI model targets inflammation, helping cardiologists find 'invisible' heart patients

By focusing more on inflammation, cardiologists can ensure they are identifying patients who need help before it's too late.

Anne Kroman, DO, PhD, Medical University of South Carolina, discusses trends in EP device lead management.

Why long-term EP lead management is as important as ever

Anne Kroman, DO, PhD, noted that early, aggressive treatment is critical when EP leads need to be removed. 

Stephanie Golab, MD, NYU Grossman School of Medicine, explains statistics on heart transplant outcomes in older adults

It may be time to revisit patient selection protocols for heart transplants

In a new video interview, Stephanie Golab, MD, examines the latest data on heart transplant outcomes in older adults.

Video of Renee Bullock-Palmer, MD, FSCCT, director, Women’s Heart Center, and director, non-invasive cardiac imaging, at the Deborah Heart and Lung Center in Browns Mills, New Jersey, explaining the latest guidelines that support use of CT angiography at SCCT 2023. #YesCCT #CCTA #CTA #SCCT #SCCT23 #SCCT2023

What new data, expert guidelines tell us about the future of cardiac CT

Renee Bullock-Palmer, MD, details the latest guidelines that support the continued use of CT angiography.

Video of Yousif Ahmad, MD, Yale, discussing IVL advances and increased reinbursements

Tracking key advances in intravascular lithotripsy

Yousif Ahmad, MD, spoke with Cardiovascular Business about the latest advances in IVL therapy, including new reimbursement changes for the technology. 

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.